BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24077574)

  • 21. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
    van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
    Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriers.
    Koçoğlu C; Gossye H; Dillen L; Van Mossevelde S; De Bleecker JL; Vandenberghe R; De Deyn PP; Sleegers K; Cras P; Engelborghs S; Van Broeckhoven C; van der Zee J;
    Neurobiol Aging; 2021 Jan; 97():145.e1-145.e4. PubMed ID: 32921502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
    Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
    Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Casalena A; Oppi F; Ambrosetto G; Montagna P; Liguori R; Parchi P; Capellari S
    J Alzheimers Dis; 2018; 62(2):687-697. PubMed ID: 29480190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
    Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
    Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
    Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
    Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.
    Pletnikova O; Sloane KL; Renton AE; Traynor BJ; Crain BJ; Reid T; Zu T; Ranum LP; Troncoso JC; Rabins PV; Onyike CU
    Neurobiol Aging; 2014 Oct; 35(10):2419.e17-21. PubMed ID: 24819148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [C9orf72-associated frontotemporal dementia in the Russian population].
    Shpilyukova YA; Fedotova EY; Berdnikovich ES; Konovalov RN; Zakharova MN; Grishina DA; Yakhno NN; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(9):98-106. PubMed ID: 33081454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.
    Kim EJ; Kwon JC; Park KH; Park KW; Lee JH; Choi SH; Jeong JH; Kim BC; Yoon SJ; Yoon YC; Kim S; Park KC; Choi BO; Na DL; Ki CS; Kim SH
    Neurobiol Aging; 2014 May; 35(5):1213.e13-7. PubMed ID: 24387985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.
    Snowden JS; Rollinson S; Thompson JC; Harris JM; Stopford CL; Richardson AM; Jones M; Gerhard A; Davidson YS; Robinson A; Gibbons L; Hu Q; DuPlessis D; Neary D; Mann DM; Pickering-Brown SM
    Brain; 2012 Mar; 135(Pt 3):693-708. PubMed ID: 22300873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
    Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
    J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.
    Rutherford NJ; Heckman MG; Dejesus-Hernandez M; Baker MC; Soto-Ortolaza AI; Rayaprolu S; Stewart H; Finger E; Volkening K; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Knopman DS; Kretzschmar HA; Neumann M; Caselli RJ; White CL; Mackenzie IR; Petersen RC; Strong MJ; Miller BL; Boeve BF; Uitti RJ; Boylan KB; Wszolek ZK; Graff-Radford NR; Dickson DW; Ross OA; Rademakers R
    Neurobiol Aging; 2012 Dec; 33(12):2950.e5-7. PubMed ID: 22840558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family.
    Siuda J; Lewicka T; Bujak M; Opala G; Golenia A; Slowik A; van Blitterswijk M; Baker M; Ertekin-Taner N; Wszolek ZK; Rademakers R
    Eur Neurol; 2014; 72(1-2):64-71. PubMed ID: 24861139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
    van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
    Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTD/ALS families are no longer orphaned: the C9ORF72 story.
    van Swieten JC; Grossman M
    Neurology; 2012 Sep; 79(10):962-4. PubMed ID: 22875094
    [No Abstract]   [Full Text] [Related]  

  • 39. Glial Cell Dysfunction in
    Ghasemi M; Keyhanian K; Douthwright C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.
    Takada LT; Pimentel ML; Dejesus-Hernandez M; Fong JC; Yokoyama JS; Karydas A; Thibodeau MP; Rutherford NJ; Baker MC; Lomen-Hoerth C; Rademakers R; Miller BL
    Arch Neurol; 2012 Sep; 69(9):1149-53. PubMed ID: 22964910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.